ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)

Technical Analysis Report for USA stock GSK Glaxosmithkline Plc. Dated: 10 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc

Glaxosmithkline Plc Opened at 58.33 and Closed at: 58.23, which is -0.22% of previous session's close. It moved within a range of 58.19 and 59.06
The session was a Bearish session with an average volume of 3451616, which is -0.41% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Golden cross was found 5 days back on short term averages

Support for tomorrow is 57.78 and resistance for tomorrow is 58.65
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 57.93, 57.62 resistance for tomorrow's hourly charts is 58.8, 59.36

10 Day SMA for Glaxosmithkline Plc (GSK) is 56.21 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Glaxosmithkline Plc (GSK) is 54.74 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Glaxosmithkline Plc (GSK) is 56.35 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 52.53 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Glaxosmithkline Plc is 46.69 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Glaxosmithkline Plc is at 54.74 and 200 DMA is at 46.69, while 50 DMA and 100 DMA are at 56.35 and 52.53 respectively

Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 54.74 and 20 EMA is at 55.84

Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 56.35 and 50 EMA is at 54.94

Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 52.53 and 100 EMA is at 52.56

Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 46.69 and 200 EMA is at 48.56

Teleflex Incorporated has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Teleflex Incorporated, about 2.08% more returns!

Glaxosmithkline Plc has performed better than Takeda Pharmaceutical in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc has performed better than Chemed Corp in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc has performed better than Bristol Myers in short term. Holding Glaxosmithkline Plc could be a better choice for now!

United Therapeutics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in United Therapeutics, about 0.02% more returns!

Glaxosmithkline Plc has performed better than Replimune Group in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc has performed better than Pulse Biosciences in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc has performed better than Phio Pharmaceuticals in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc has performed better than Henry Schein in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc has performed better than Galectin Therapeutics in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc has performed better than Fonar Corporation in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Eton Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 31.31% more returns!

Glaxosmithkline Plc has performed better than Dbv Technologies in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Celldex Therapeutics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 0.62% more returns!

Glaxosmithkline Plc has performed better than Celcuity Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc has performed better than Axogen Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!

Glaxosmithkline Plc Technical analysis of indicators

Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Glaxosmithkline Plc stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Glaxosmithkline Plc in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Glaxosmithkline Plc Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down

CCI has generated a buy signal for Glaxosmithkline Plc in short term and BUY signal is strong.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Glaxosmithkline Plc is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 56.2 and Glaxosmithkline Plc GSK stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.

Glaxosmithkline Plc Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And GSK Experts View which covers a lot of information including buying and selling signals

GSK future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here

Chart Glaxosmithkline Plc (GSK)  Technical (Analysis) Reports Glaxosmithkline Plc [

Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Glaxosmithkline Plc (GSK)  Technical (Analysis) Reports Glaxosmithkline Plc [

 

Back to top